Palisades Compounding Pharmacy
FDA inspection history across 2 sites, 2023
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2023: one warning letter and one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One warning letter and one Form 483, at California and Pacific Palisades, California.
Cited most
Across all Palisades Compounding Pharmacy observations on file
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
- FDCA 501(a)(2)(A)Insanitary conditions1
The complete Palisades Compounding Pharmacy file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
California
One warning letter · 2023
Latest: Warning letter, Sep 27, 2023 →Pacific Palisades, California
One Form 483 · 2023 · 2 observations
Latest: Form 483, Mar 15, 2023 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-09-27 | Warning letter Warning letter | California | — | $99 |
| 2023-03-15 | 483 Form 483 | Pacific Palisades, California | 2 | $99 |
Investigators on these documents
FEI number 3008174851 · most recent document Sep 27, 2023
About Palisades Compounding Pharmacy
How many FDA Form 483s has Palisades Compounding Pharmacy received?
FDA Intel has 1 Form 483 on file for Palisades Compounding Pharmacy; the most recent is dated Mar 15, 2023.
When was Palisades Compounding Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for Palisades Compounding Pharmacy is a Form 483 dated Mar 15, 2023, for the site in Pacific Palisades, California.
What did FDA cite at Palisades Compounding Pharmacy?
The regulations cited most in the observations on file for Palisades Compounding Pharmacy are 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 1 time; FDCA 501(a)(2)(A) (Insanitary conditions), 1 time.
Has Palisades Compounding Pharmacy received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Palisades Compounding Pharmacy; the most recent is dated Sep 27, 2023.